Table 2

Comparison of the metabolic complications and adipose tissue areas between subjects with and without MES except waist circumference

Female (N=192)Male (N=177)
None or one metabolic risk factor (N=51)Two or more metabolic risk factors (N=141)P valueNone or one metabolic risk factor (N=38)Two or more metabolic risk factors (N=139)P value
Age (years)42.9±12.954.2±14.4<0.00144.3±17.555.2±14.2<0.001
BMI (kg/m2)30.9±8.932.8±8.30.17827.6±8.228.9±6.50.328
BP ≥130/85 mm Hg or medication9 (17.6)98 (69.5)<0.0015 (13.2)106 (76.3)<0.001
High FPG, N (%)11 (21.6)129 (91.5)<0.00111 (28.9)127 (91.4)<0.001
High TG, N (%)1 (2.0)57 (40.4)<0.0013 (7.9)45 (32.4)0.003
Low HDL-C, N (%)12 (23.5)108 (76.6)<0.0015 (13.2)90 (64.7)<0.001
Greater SAT area than the field of view, N (%)27 (52.9)72 (51.1)0.8188 (21.1)17 (12.2)0.166
VAT (cm2)*129.3±9.2153.2±5.40.029118.9±11.5167.6±5.9<0.001
SAT (cm2)*313.3±19.3345.9±11.30.155227.1±25.0255.8±12.70.315
VSR*0.443±0.00.485±0.00.2490.622±0.10.768±0.00.027
  • *Means±SE are adjusted for age in same-gender group.

  • BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; SAT, subcutaneous adipose tissue; TG, triglyceride; VAT, visceral adipose tissue; VSR, visceral-to-subcutaneous fat ratio.